Literature DB >> 25693977

4-Hydroxy-2-nonenal attenuates β2-adrenoceptor-mediated vasodilation of rat retinal arterioles.

Asami Mori1, Toshiaki Takei, Kenji Sakamoto, Tsutomu Nakahara, Kunio Ishii.   

Abstract

4-Hydroxy-2-nonenal (4-HNE) is a major reactive aldehyde formed by lipid peroxidation, and it plays an important role in the pathogenesis of several vascular diseases, including diabetes mellitus. In this study, we examined the effects of 4-HNE on the vasodilatory mechanisms of rat retinal arterioles. The retinal vasodilator responses were assessed by measuring the diameter of retinal arterioles in the fundus images. Intravitreal injection of 4-HNE significantly prevented the vasodilation of retinal arterioles induced by the β2-adrenoceptor agonist salbutamol but not the nitric oxide donor (±)-(E)-4-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide (NOR3). Iberiotoxin, an inhibitor of large-conductance KCa (BKCa) channels, significantly reduced the salbutamol-induced vasodilation of retinal arterioles. The vasodilator effect of BMS-191011, a BKCa channel opener, on retinal arterioles was significantly attenuated by 4-HNE. These results suggest that 4-HNE attenuates retinal vasodilator responses to β2-adrenoceptor agonists through the impairment of the BKCa pathway. The direct effect of 4-HNE on retinal blood vessels may, therefore, contribute to the retinal vascular dysfunction observed in patients with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25693977     DOI: 10.1007/s00210-015-1099-0

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  35 in total

1.  Pharmacological evidence for the presence of functional beta(3)-adrenoceptors in rat retinal blood vessels.

Authors:  Asami Mori; Tomoyo Miwa; Kenji Sakamoto; Tsutomu Nakahara; Kunio Ishii
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-05-26       Impact factor: 3.000

2.  Role of calcium-activated potassium channels in acetylcholine-induced vasodilation of rat retinal arterioles in vivo.

Authors:  Asami Mori; Sachi Suzuki; Kenji Sakamoto; Tsutomu Nakahara; Kunio Ishii
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-27       Impact factor: 3.000

Review 3.  Endothelial dysfunction in diabetes.

Authors:  A S De Vriese; T J Verbeuren; J Van de Voorde; N H Lameire; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Retinal circulatory abnormalities in type 1 diabetes.

Authors:  G T Feke; S M Buzney; H Ogasawara; N Fujio; D G Goger; N P Spack; K H Gabbay
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-06       Impact factor: 4.799

5.  Retinal proteins modified by 4-hydroxynonenal: identification of molecular targets.

Authors:  Rebecca J Kapphahn; Babatomiwa M Giwa; Kristin M Berg; Heidi Roehrich; Xiao Feng; Timothy W Olsen; Deborah A Ferrington
Journal:  Exp Eye Res       Date:  2006-03-10       Impact factor: 3.467

Review 6.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

Authors:  H Esterbauer; R J Schaur; H Zollner
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

7.  Hyperglycemia accelerates impairment of vasodilator responses to acetylcholine of retinal blood vessels in rats.

Authors:  Asami Mori; Orie Saigo; Masayuki Hanada; Tsutomu Nakahara; Kunio Ishii
Journal:  J Pharmacol Sci       Date:  2009-06-05       Impact factor: 3.337

8.  Attenuation of endothelium-dependent relaxation in aorta from diabetic rats.

Authors:  Y Oyama; H Kawasaki; Y Hattori; M Kanno
Journal:  Eur J Pharmacol       Date:  1986-12-02       Impact factor: 4.432

9.  Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal.

Authors:  Cheryl M Ethen; Cavan Reilly; Xiao Feng; Timothy W Olsen; Deborah A Ferrington
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

Review 10.  Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives.

Authors:  Ying Wu; Luosheng Tang; Baihua Chen
Journal:  Oxid Med Cell Longev       Date:  2014-08-10       Impact factor: 6.543

View more
  3 in total

1.  Probucol prevents the attenuation of β2-adrenoceptor-mediated vasodilation of retinal arterioles in diabetic rats.

Authors:  Asami Mori; Kentaro Higashi; Shun Wakao; Kenji Sakamoto; Kunio Ishii; Tsutomu Nakahara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-09-14       Impact factor: 3.000

2.  Meta-Analysis on the Association of ALDH2 Polymorphisms and Type 2 Diabetic Mellitus, Diabetic Retinopathy.

Authors:  Guang-Yi Li; Zi-Bo Li; Fang Li; Li-Ping Dong; Liang Tang; Ju Xiang; Jian-Ming Li; Mei-Hua Bao
Journal:  Int J Environ Res Public Health       Date:  2017-02-08       Impact factor: 3.390

3.  Elevated 4-hydroxynonenal induces hyperglycaemia via Aldh3a1 loss in zebrafish and associates with diabetes progression in humans.

Authors:  Bowen Lou; Mike Boger; Katrin Bennewitz; Carsten Sticht; Stefan Kopf; Jakob Morgenstern; Thomas Fleming; Rüdiger Hell; Zuyi Yuan; Peter Paul Nawroth; Jens Kroll
Journal:  Redox Biol       Date:  2020-09-16       Impact factor: 11.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.